GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway

Pathological cardiac hypertrophy is a process of abnormal remodeling of cardiomyocytes in response to pressure overload or other stress stimuli, resulting in myocardial injury, which is a major risk factor for heart failure, leading to increased morbidity and mortality. General control nonrepressed...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jia, Yan, Chenghui, Wang, Yilong, Chen, Can, Yu, Haibo, Liu, Dan, Huang, Kai, Han, Yaling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056507/
https://www.ncbi.nlm.nih.gov/pubmed/35490166
http://dx.doi.org/10.1038/s41419-022-04881-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056507/
https://www.ncbi.nlm.nih.gov/pubmed/35490166
http://dx.doi.org/10.1038/s41419-022-04881-y

Ejemplares similares